After original cancer relapse and second cancers, cardiovascular disease is now the most common cause of premature morbidity and mortality among long-term childhood cancer survivors. This presentation will review the epidemiologic risk factors for early cardiovascular disease in this high-risk population, new prediction tools being developed to more accurately identify those at risk, and conclude with a survey of potential intervention strategies whereby cardiovascular risk may be ameliorated.
Eric Chow, MD, MPH
Medical Director, Cancer Survivor Program
Seattle Children’s Hospital
Assistant Professor of Pediatrics, University of Washington, Seattle Children’s Hospital, Fred Hutchinson Cancer Research Center
Dr. Chow earned his MPH from the University of California, Berkeley, and completed his medical degree at the University of California, San Francisco. He is a pediatric oncologist and epidemiologist, and his clinical and research focus is on pediatric cancer survivorship. Dr. Chow serves as the Medical Director of the Cancer Survivor Program at Seattle Children’s Hospital, and holds leadership roles within both the Childhood Cancer Survivor Study (CCSS) and the Children’s Oncology Group’s Survivorship and Outcomes committees. Dr. Chow’s clinical and research goals are to improve the care of all people who have had cancer through well-designed and detailed follow-up studies, with a particular focus on cardiovascular health following treatment for childhood cancer and after hematopoietic cell transplantation.